CA2471307A1 - Complexes de proteines et leurs procedes d'utilisation - Google Patents

Complexes de proteines et leurs procedes d'utilisation Download PDF

Info

Publication number
CA2471307A1
CA2471307A1 CA002471307A CA2471307A CA2471307A1 CA 2471307 A1 CA2471307 A1 CA 2471307A1 CA 002471307 A CA002471307 A CA 002471307A CA 2471307 A CA2471307 A CA 2471307A CA 2471307 A1 CA2471307 A1 CA 2471307A1
Authority
CA
Canada
Prior art keywords
complex
protein
activity
proteins
limited
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002471307A
Other languages
English (en)
Inventor
Andreas Bauer
Anne-Claude Gavin
Gulio Superti-Furga
Bernhard Kuster
Jorg Schultz
Martina Marzioch
Paola Grandi
Roland Krause
Ulrich Kruse
Alejandro Merino
Angela Bauch
Anne-Marie Michon
Christina Leutwein
Jens Rick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Cellzome GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01130253A external-priority patent/EP1258494A1/fr
Application filed by Cellzome GmbH filed Critical Cellzome GmbH
Publication of CA2471307A1 publication Critical patent/CA2471307A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne des complexes multiprotéiques tirés d'eukaryotes. Les complexes peuvent être obtenus par utilisation d'une protéine en tant qu'appât et par isolement de l'ensemble de protéines qui lui est attaché à partir de cellules. Ces complexes protéiques peuvent contenir jusqu'à trente protéines distinctes.
CA002471307A 2001-12-20 2002-12-20 Complexes de proteines et leurs procedes d'utilisation Abandoned CA2471307A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01130253.6 2001-12-20
EP01130253A EP1258494A1 (fr) 2001-05-15 2001-12-20 Complexe multiprotétique eucaryote
PCT/EP2002/050003 WO2003072602A2 (fr) 2001-12-20 2002-12-20 Complexes de proteines et leurs procedes d'utilisation

Publications (1)

Publication Number Publication Date
CA2471307A1 true CA2471307A1 (fr) 2003-09-04

Family

ID=27763328

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002471307A Abandoned CA2471307A1 (fr) 2001-12-20 2002-12-20 Complexes de proteines et leurs procedes d'utilisation

Country Status (3)

Country Link
AU (1) AU2002367554A1 (fr)
CA (1) CA2471307A1 (fr)
WO (1) WO2003072602A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007521837A (ja) 2004-02-13 2007-08-09 マーテック・バイオサイエンシーズ・コーポレーション シゾチトリウム脂肪酸合成酵素(fas)ならびにそれに関連した製品および方法
CN100577805C (zh) * 2005-03-16 2010-01-06 中国科学院沈阳应用生态研究所 一种基因改组的方法及所获得的重组基因和编码蛋白
CN1861789B (zh) * 2005-05-13 2010-04-28 中国科学院沈阳应用生态研究所 一种综合的基因改组方法及所获得的重组基因和编码蛋白
JP5616220B2 (ja) 2007-06-01 2014-10-29 ザ トラスティーズ オブ プリンストン ユニバーシティ 宿主細胞代謝経路の調節によるウイルス感染治療
RU2483107C2 (ru) * 2007-07-31 2013-05-27 Сэ5 Лигно Текнолоджиз ин Лунд АБ Полипептид, имеющий nadh-зависимую hmf-редуктазную активность
PT104619A (pt) * 2008-06-13 2009-12-14 Biocant Ct De Inovacao Em Biot Complexos de proteína e métodos de rastreio
CN103209987B (zh) 2010-09-22 2017-06-06 艾丽奥斯生物制药有限公司 取代的核苷酸类似物
AU2012358804B2 (en) 2011-12-22 2018-04-19 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
WO2013142124A1 (fr) 2012-03-21 2013-09-26 Vertex Pharmaceuticals Incorporated Formes solides d'un promédicament nucléotidique thiophosphoramidate
US9012427B2 (en) 2012-03-22 2015-04-21 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
US11312979B2 (en) 2017-02-17 2022-04-26 Hyasynth Biologicals Inc. Method and cell line for production of phytocannabinoids and phytocannabinoid analogues in yeast
CN113774074A (zh) * 2020-06-05 2021-12-10 复旦大学 一种基于肽段的靶向蛋白质组精确定量方法
WO2024030080A1 (fr) * 2022-08-05 2024-02-08 Nanyang Technological University Protéine et motifs spécifiques de l'adp-actine pour remodeler le cytosquelette de l'actine en biochimie de cellules vivantes et in vitro
CN118389492B (zh) * 2024-07-01 2024-10-15 广州凯普医药科技有限公司 一种磁珠法提取干血斑基因组dna的试剂盒及其应用

Also Published As

Publication number Publication date
WO2003072602A3 (fr) 2004-04-15
WO2003072602A2 (fr) 2003-09-04
AU2002367554A1 (en) 2003-09-09

Similar Documents

Publication Publication Date Title
Ando et al. IRBIT, a novel inositol 1, 4, 5-trisphosphate (IP3) receptor-binding protein, is released from the IP3 receptor upon IP3 binding to the receptor
Mayeda et al. Purification and characterization of human RNPS1: a general activator of pre-mRNA splicing
WO2004009622A2 (fr) Complexes de proteiniques de reseaux cellulaires fondant le developpement du cancer et d'autres maladies
Welch et al. RanBP3 contains an unusual nuclear localization signal that is imported preferentially by importin-α3
CA2471307A1 (fr) Complexes de proteines et leurs procedes d'utilisation
US20040167066A1 (en) Cleavage and polyadenylation complex of precursor mrna
US20060216292A1 (en) Treatment of neurodegenerative diseases
WO2005023858A1 (fr) Complexes proteiniques associes au traitement de la proteine precurseur amyloide
US20080176803A1 (en) Components of the presenilin-complex
US20030023034A1 (en) p27 (Kip1) -FKBP-12 protein complexes
EP1403282A1 (fr) Complexes de protéines de la voie de signalisation du facteur de nécrose tumorale-alpha (TNF-alpha)
WO2004035783A2 (fr) Complexes proteiques de la voie de signalisation du facteur de necrose tumorale alpha
EP1582586A1 (fr) Proteine associee a l'apoptose et son utilisation
US20060264610A1 (en) Protein complexes of the tip60 transcriptional activator protein
Yan et al. A seven-sex species recognizes self and non-self mating-type via a novel protein complex
WO2004031242A2 (fr) Complexes proteiques impliques dans des maladies neurologiques
US20240294587A1 (en) K-ras inhibitor
Bisnett Regulation of Sec24 by O-GlcNAcylation
WO2000058472A9 (fr) Adn isole codant pour des regulateurs cullin roc1 et roc2, proteines isolees codees par ledit adn. procedes d'utilisation associes
EP2155895A2 (fr) Procédés et utilisations relatifs à rhbdl4
Mayoral A Diverse Toolkit: Studies on Secreted Proteins from the Parasite Toxoplasma gondii
US6812336B1 (en) Transcription factor coactivator protein, p/CIP
Cheney On the leukemogenic mechanisms of core binding factor translocation products
Fong Functional characterization of a novel protein, CDK5RAP2, in microtubule organization and regulation
Akıllılar Characterization of the Coiled-Coil Domain-Containing Protein 124 (Ccdc124) as a Novel Centrosome and Midbody Component Involved in Cytokinesis

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued